Flash Buy: Trade the Catalyst on This Beat-Down Pharma Play
We’ve had some good success in the past trading drug catalysts… Now an upcoming COVID-19 catalyst could pull the pin on a profit grenade for one tiny pharma firm.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!